NCT06101927 Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 Status COMPLETED Phase PHASE1
NCT06101290 Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) Status RECRUITING Phase NA
NCT06099093 Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan Status RECRUITING Phase PHASE4
NCT06096870 Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy Status RECRUITING Phase PHASE2
NCT06094322 Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging Status COMPLETED Phase NA
NCT06085729 Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) Status RECRUITING Phase PHASE1/PHASE2
NCT06085664 A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy Status RECRUITING Phase PHASE1/PHASE2
NCT06084338 Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc Status RECRUITING Phase PHASE2
NCT06081686 Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06080113 Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source Status ENROLLING_BY_INVITATION Phase NA
NCT06075498 Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block Status COMPLETED Phase NA
NCT06074510 PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06072911 Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer Status RECRUITING Phase NA
NCT06066437 NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06065592 Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms Status RECRUITING Phase PHASE1